Stocks and InvestingStocks and Investing
Mon, October 25, 2021
Sun, October 24, 2021
Fri, October 22, 2021
Thu, October 21, 2021

Phil Nadeau Maintained (BIIB) at Buy with Decreased Target to $375 on, Oct 21st, 2021


Published on 2024-10-27 18:15:24 - WOPRAI, Phil Nadeau
  Print publication without navigation


Phil Nadeau of Cowen & Co., Maintained "Biogen Inc." (BIIB) at Buy with Decreased Target from $450 to $375 on, Oct 21st, 2021.

Phil has made no other calls on BIIB in the last 4 months.



There are 7 other peers that have a rating on BIIB. Out of the 7 peers that are also analyzing BIIB, 3 agree with Phil's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Alethia Young of "Cantor Fitzgerald" Maintained at Hold with Decreased Target to $327 on, Friday, October 15th, 2021
  • Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $290 on, Friday, October 8th, 2021
  • Salim Syed of "Mizuho" Maintained at Hold with Increased Target to $300 on, Monday, August 2nd, 2021


These are the ratings of the 4 analyists that currently disagree with Phil


  • Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $344 on, Friday, October 15th, 2021
  • Michael Yee of "Jefferies" Maintained at Strong Buy with Decreased Target to $400 on, Friday, October 8th, 2021
  • Colin Bristow of "UBS" Maintained at Strong Buy with Decreased Target to $442 on, Thursday, September 16th, 2021
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $423 on, Tuesday, July 27th, 2021